Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Leading No Fee Savings Accounts Rates highlight current top yields and terms for zero-fee savings. Compare rates and access across providers.
19,858 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A sharp selloff in optical interconnect makers hits Applied Optoelectronics as it plunges 13%, prompting questions ab...
Whether you’re entering the field or leveling up, the right resources make all the difference. This guide maps the be...
Supermicro sits at the intersection of exploding AI demand and serious credibility concerns. This article breaks down...
Meta is pursuing prediction markets, signaling a major shift away from its metaverse push. The move could reshape its...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
A high-profile health hiccup on opening night offers a blunt lesson in personal finance for fans and performers. Lear...
CFOs are bullish about their own firms even as the broader economy slows, according to Deloitte's Q2 2026 CFO Signals...
New Census Bureau data reveals a stark generational imbalance: aging baby boomers dominate assets while younger Ameri...
Tensions flare in the Persian Gulf as tit-for-tat attacks continue across the region despite a tentative U.S.-Iran ce...
Nike looks undervalued here may be more than a short-term swing. This article breaks down why patient investors could...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...